Targeting Glutamine Metabolism for Cancer Treatment

被引:239
作者
Choi, Yeon-Kyung [1 ]
Park, Keun-Gyu [1 ]
机构
[1] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu 41944, South Korea
关键词
Cancer; Glutamine; Anaplerosis; Redox homeostasis; PHOSPHATE-ACTIVATED GLUTAMINASE; OXIDATIVE STRESS; CELL BIOLOGY; TUMOR-GROWTH; AUTOPHAGY; MTOR; RESISTANCE; EXPRESSION; SURVIVAL; GLS2;
D O I
10.4062/biomolther.2017.178
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Rapidly proliferating cancer cells require energy and cellular building blocks for their growth and ability to maintain redox balance. Many studies have focused on understanding how cancer cells adapt their nutrient metabolism to meet the high demand of anabolism required for proliferation and maintaining redox balance. Glutamine, the most abundant amino acid in plasma, is a well-known nutrient used by cancer cells to increase proliferation as well as survival under metabolic stress conditions. In this review, we provide an overview of the role of glutamine metabolism in cancer cell survival and growth and highlight the mechanisms by which glutamine metabolism affects cancer cell signaling. Furthermore, we summarize the potential therapeutic approaches of targeting glutamine metabolism for the treatment of numerous types of cancer.
引用
收藏
页码:19 / 28
页数:10
相关论文
共 86 条
  • [1] Redox control of glutamine utilization in cancer
    Alberghina, L.
    Gaglio, D.
    [J]. CELL DEATH & DISEASE, 2014, 5 : e1561 - e1561
  • [2] From Krebs to clinic: glutamine metabolism to cancer therapy (vol 16, pg 619, 2016)
    Altman, Brian J.
    Stine, Zachary E.
    Dang, Chi V.
    [J]. NATURE REVIEWS CANCER, 2016, 16 (12) : 773 - 773
  • [3] Resistance to BRAF inhibitors induces glutamine dependency in melanoma cells
    Baenke, Franziska
    Chaneton, Barbara
    Smith, Matthew
    Van Den Broek, Niels
    Hogan, Kate
    Tang, Haoran
    Viros, Amaya
    Martin, Matthew
    Galbraith, Laura
    Girotti, Maria R.
    Dhomen, Nathalie
    Gottlieb, Eyal
    Marais, Richard
    [J]. MOLECULAR ONCOLOGY, 2016, 10 (01) : 73 - 84
  • [4] The two TORCs and Akt
    Bhaskar, Prashanth T.
    Hay, Nissim
    [J]. DEVELOPMENTAL CELL, 2007, 12 (04) : 487 - 502
  • [5] Amino Acid Transporters in Cancer and Their Relevance to "Glutamine Addiction": Novel Targets for the Design of a New Class of Anticancer Drugs
    Bhutia, Yangzom D.
    Babu, Ellappan
    Ramachandran, Sabarish
    Ganapathy, Vadivel
    [J]. CANCER RESEARCH, 2015, 75 (09) : 1782 - 1788
  • [6] Metabolic pathways promoting cancer cell survival and growth
    Boroughs, Lindsey K.
    DeBerardinis, Ralph J.
    [J]. NATURE CELL BIOLOGY, 2015, 17 (04) : 351 - 359
  • [7] KRAS: feeding pancreatic cancer proliferation
    Bryant, Kirsten L.
    Mancias, Joseph D.
    Kimmelman, Alec C.
    Der, Channing J.
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 2014, 39 (02) : 91 - 100
  • [8] Alanyl-glutamine consumption modifies the suppressive effect of L-asparaginase on lymphocyte Populations in mice1,2
    Bunpo, Piyawan
    Murray, Betty
    Cundiff, Judy
    Brizius, Emma
    Aldrich, Carla J.
    Anthony, Tracy G.
    [J]. JOURNAL OF NUTRITION, 2008, 138 (02) : 338 - 343
  • [9] A Positive Feedback Loop between Sestrin2 and mTORC2 Is Required for the Survival of Glutamine-Depleted Lung Cancer Cells
    Byun, Jun-Kyu
    Choi, Yeon-Kyung
    Kim, Ji-Hyun
    Jeong, Ji Yun
    Jeon, Hui-Jeon
    Kim, Mi-Kyung
    Hwang, Ilseon
    Lee, Shin-Yup
    Lee, You Mie
    Lee, In-Kyu
    Park, Keun-Gyu
    [J]. CELL REPORTS, 2017, 20 (03): : 586 - 599
  • [10] Targeting Glutamine Induces Apoptosis: A Cancer Therapy Approach
    Chen, Lian
    Cui, Hengmin
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2015, 16 (09) : 22830 - 22855